{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:09:18Z","timestamp":1790906958628,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T00:00:00Z","timestamp":1141257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T00:00:00Z","timestamp":1141257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1038\/sj.gt.3302711","type":"journal-article","created":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T08:34:37Z","timestamp":1141288477000},"page":"933-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["NF\u03baB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts"],"prefix":"10.1038","volume":"13","author":[{"given":"H","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kunugiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,2]]},"reference":[{"key":"BF3302711_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/excr.1998.4320","volume":"247","author":"E Jimi","year":"1999","unstructured":"Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells. Exp Cell Res 1999; 247: 84\u201393.","journal-title":"Exp Cell Res"},{"key":"BF3302711_CR2","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1210\/endo-129-3-1596","volume":"129","author":"G van der Pluijm","year":"1991","unstructured":"van der Pluijm G, Most W, van der Wee-Pals L, deGroot H, Papapoulos S, Lowik C . Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology 1991; 129: 1596\u20131604.","journal-title":"Endocrinology"},{"key":"BF3302711_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315\u2013323.","journal-title":"Nature"},{"key":"BF3302711_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165\u2013176.","journal-title":"Cell"},{"key":"BF3302711_CR5","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597\u20133602.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302711_CR6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000; 97: 1566\u20131571.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302711_CR7","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","volume":"87","author":"N Udagawa","year":"1990","unstructured":"Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990; 87: 7260\u20137264.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302711_CR8","first-page":"66","volume":"13","author":"T Suda","year":"1992","unstructured":"Suda T, Takahashi N, Martin TJ . Modulation of osteoclast differentiation. Endocr Rev 1992; 13: 66\u201380.","journal-title":"Endocr Rev"},{"key":"BF3302711_CR9","doi-asserted-by":"publisher","first-page":"87S","DOI":"10.1016\/8756-3282(95)00185-G","volume":"17","author":"T Suda","year":"1995","unstructured":"Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N . Modulation of osteoclast differentiation by local factors. Bone 1995; 17: 87S\u201391S.","journal-title":"Bone"},{"key":"BF3302711_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/rheumatology\/39.7.749","volume":"39","author":"T Tomita","year":"2000","unstructured":"Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K et al. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 749\u2013757.","journal-title":"Rheumatology (Oxford)"},{"key":"BF3302711_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS . NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680\u20131683.","journal-title":"Science"},{"key":"BF3302711_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1359\/jbmr.1998.13.2.271","volume":"13","author":"M Sugimoto","year":"1998","unstructured":"Sugimoto M, Hirota S, Sato M, kawahata H, Tsukamoto I, Yasui N et al. Impaired expression of noncollagenous bone matrix protein mRNAs during fracture healing in ascorbic acid-deficient rats. J Bone Miner Res 1998; 13: 271\u2013278.","journal-title":"J Bone Miner Res"},{"key":"BF3302711_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med 2000; 191: 275\u2013286.","journal-title":"J Exp Med"},{"key":"BF3302711_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0006-2952(03)00470-2","volume":"66","author":"L Penolazzi","year":"2003","unstructured":"Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I et al. Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 2003; 66: 1189\u20131198.","journal-title":"Biochem Pharmacol"},{"key":"BF3302711_CR15","first-page":"115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas SC . Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115\u2013137.","journal-title":"Endocr Rev"},{"key":"BF3302711_CR16","doi-asserted-by":"crossref","unstructured":"2001 NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7\u201329, highlights of the conference. South Med J 2000; 94: 569\u2013573.","DOI":"10.1097\/00007611-200194060-00004"},{"key":"BF3302711_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0065-2776(08)60891-3","volume":"64","author":"M Feldmann","year":"1997","unstructured":"Feldmann M, Elliott MJ, Woody JN, Maini RN . Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv Immunol 1997; 64: 283\u2013350.","journal-title":"Adv Immunol"},{"key":"BF3302711_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/art.1780380202","volume":"38","author":"WP Arend","year":"1995","unstructured":"Arend WP, Dayer JM . Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38: 151\u2013160.","journal-title":"Arthritis Rheum"},{"key":"BF3302711_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/art.1780361206","volume":"36","author":"MJ Elliott","year":"1993","unstructured":"Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36: 1681\u20131690.","journal-title":"Arthritis Rheum"},{"key":"BF3302711_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF00200533","volume":"13","author":"PF Piguet","year":"1992","unstructured":"Piguet PF . Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin. Springer Semin Immunopathol 1992; 13: 345\u2013354.","journal-title":"Springer Semin Immunopathol"},{"key":"BF3302711_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nm1054","volume":"10","author":"E Jimi","year":"2004","unstructured":"Jimi E, Aoki K, Saito H, D\u2019Acquisto F, May MJ, Nakamura I et al. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 2004; 10: 617\u2013624.","journal-title":"Nat Med"},{"key":"BF3302711_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jbmr.5650050415","volume":"5","author":"H Shimizu","year":"1990","unstructured":"Shimizu H, Sakamoto M, Sakamoto S . Bone resorption by isolated osteoclasts in living versus devitalized bone: differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases. J Bone Miner Res 1990; 5: 411\u2013418.","journal-title":"J Bone Miner Res"},{"key":"BF3302711_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/01.HYP.37.2.581","volume":"37","author":"H Nakagami","year":"2001","unstructured":"Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 2001; 37: 581\u2013586.","journal-title":"Hypertension"},{"key":"BF3302711_CR24","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2337\/diabetes.50.6.1472","volume":"50","author":"H Nakagami","year":"2001","unstructured":"Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, Aoki M et al. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 2001; 50: 1472\u20131481.","journal-title":"Diabetes"},{"key":"BF3302711_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0169-6009(89)90033-0","volume":"6","author":"H Shimizu","year":"1989","unstructured":"Shimizu H, Sakamoto S, Sakamoto M, Lee DD . The effect of substrate composition and condition on resorption by isolated osteoclasts. Bone Miner 1989; 6: 261\u2013275.","journal-title":"Bone Miner"},{"key":"BF3302711_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/B978-0-12-091302-2.50067-0","volume-title":"Method of Enzymatic Analysis","author":"K Walter","year":"1974","unstructured":"Walter K, Schutt C . Acid and alkaline phosphatase in serum. Method of Enzymatic Analysis. Academic Press: New York & London, 1974: 856\u2013870."},{"key":"BF3302711_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0009-8981(70)90355-4","volume":"27","author":"I Bergman","year":"1970","unstructured":"Bergman I, Loxley R . The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 1970; 27: 347\u2013349.","journal-title":"Clin Chim Acta"},{"key":"BF3302711_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1152\/ajplegacy.1968.215.2.483","volume":"215","author":"HJ Gitelman","year":"1968","unstructured":"Gitelman HJ, Kukolj S, Welt LG . Inhibition of parathyroid gland activity by hypermagnesemia. Am J Physiol 1968; 215: 483\u2013485.","journal-title":"Am J Physiol"},{"key":"BF3302711_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bone.2005.01.003","volume":"36","author":"K Venken","year":"2005","unstructured":"Venken K, Boone S, Van Herck E, Vandenput I, Kunar N, Sitruk-Ware R et al. Bone and muscle protective potential of the prostate-sparing synthetic androgen 7\u03b1-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. Bone 2005; 36: 663\u2013670.","journal-title":"Bone"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302711","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:37:41Z","timestamp":1648615061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,2]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["BF3302711"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302711","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,2]]},"assertion":[{"value":"24 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}